Norpace - 0025-2742-31 - (disopyramide phosphate)

Alphabetical Index


Drug Information of Norpace

Product NDC: 0025-2742
Proprietary Name: Norpace
Non Proprietary Name: disopyramide phosphate
Active Ingredient(s): 150    mg/1 & nbsp;   disopyramide phosphate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, GELATIN COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Norpace

Product NDC: 0025-2742
Labeler Name: G.D. Searle LLC Division of Pfizer Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA018655
Marketing Category: NDA
Start Marketing Date: 19820720

Package Information of Norpace

Package NDC: 0025-2742-31
Package Description: 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2742-31)

NDC Information of Norpace

NDC Code 0025-2742-31
Proprietary Name Norpace
Package Description 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2742-31)
Product NDC 0025-2742
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name disopyramide phosphate
Dosage Form Name CAPSULE, GELATIN COATED
Route Name ORAL
Start Marketing Date 19820720
Marketing Category Name NDA
Labeler Name G.D. Searle LLC Division of Pfizer Inc
Substance Name DISOPYRAMIDE PHOSPHATE
Strength Number 150
Strength Unit mg/1
Pharmaceutical Classes Antiarrhythmic [EPC]

Complete Information of Norpace


General Information